International Journal of Epidemiology, Vol 20, S36-S42, Copyright © 1991 by International Epidemiological Association
MM Breteler, CM van Duijn, V Chandra, L Fratiglioni, AB Graves, A Heyman, AF Jorm, E Kokmen, K Kondo and JA Mortimer
In a re-analysis of eight case-control studies on Alzheimer's disease we
explored several medical conditions that had previously been suggested as
possible risk factors for Alzheimer's disease. History of hypothyroidism
was increased in cases as compared to controls (relative risk 2.3; 95%
confidence interval 1.0-5.4). Severe headaches and migraine were inversely
related to Alzheimer's disease (relative risk 0.7; 95% confidence interval
0.5-1.0). More cases than controls reported epilepsy before onset of
Alzheimer's disease (relative risk 1.6; 95% confidence interval 0.7-3.5),
especially for epilepsy with an onset within 10 years of onset of dementia.
Neurotropic viruses, allergic conditions, general anaesthesia and blood
transfusions were not associated with Alzheimer's disease.
ARTICLES
Medical history and the risk of Alzheimer's disease: a collaborative re- analysis of case-control studies. EURODEM Risk Factors Research Group
Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Planel, K. E. G. Richter, C. E. Nolan, J. E. Finley, L. Liu, Y. Wen, P. Krishnamurthy, M. Herman, L. Wang, J. B. Schachter, et al. Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia J. Neurosci., March 21, 2007; 27(12): 3090 - 3097. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fodale, D. Quattrone, C. Trecroci, V. Caminiti, and L. B. Santamaria Alzheimer's disease and anaesthesia: implications for the central cholinergic system Br. J. Anaesth., October 1, 2006; 97(4): 445 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Zandi, J. C. Anthony, K. M. Hayden, K. Mehta, L. Mayer, and J. C.S. Breitner Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study Neurology, September 24, 2002; 59(6): 880 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Volpato, J. M. Guralnik, L. P. Fried, A. T. Remaley, A. R. Cappola, and L. J. Launer Serum thyroxine level and cognitive decline in euthyroid older women Neurology, April 9, 2002; 58(7): 1055 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L Tyas, J. Manfreda, L. A Strain, and P. R Montgomery Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada Int. J. Epidemiol., June 1, 2001; 30(3): 590 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Small, A. F. Leuchter, M. A. Mandelkern, A. L. Rue, A. Okonek, R. B. Lufkin, L. F. Jarvik, S. S. Matsuyama, and W. Bondareff Clinical, Neuroimaging, and Environmental Risk Differences in Monozygotic Female Twins Appearing Discordant for Dementia of the Alzheimer Type Arch Neurol, February 1, 1993; 50(2): 209 - 219. [Abstract] [PDF] |
||||




